Rockwell Medical, Inc. RMTI
8.37
(0.20)
(2.33%)
as of 25 Sep
- Market cap
- $34.5M
- P/E
- 0.0×
Follow RMTI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(17.14%) | (15.28%) | (16.04%) | (15.53%) | |
| (9.90%) | (9.13%) | (9.70%) | (9.32%) | ||
ROIC |
(13.38%) | (13.89%) | (14.27%) | (14.58%) | |
Return on Tangible Assets |
(17.24%) | (16.00%) | (17.21%) | (17.06%) | |
Average Days of Receivables |
40.22 | 42.91 | 47.59 | 43.69 | |
Free Cash Flow per Share |
(0.81) | (0.33) | 0.49 | 0.43 | |
Free Cash Flow |
(2.94) | (1.20) | 1.93 | 1.72 | |
Capital Expenditures |
(0.85) | (0.54) | (0.73) | (1.18) | |
Piotroski F-Score |
3.00 | 2.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(2.98%) | (0.93%) | 3.86% | 4.20% | |
Accounts Receivable Turnover |
8.78 | 8.43 | 7.32 | 8.47 | |
Accounts Payable Turnover |
31.06 | 23.65 | 20.90 | 24.40 | |
Inventory Turnover |
13.02 | 12.51 | 13.86 | 16.37 | |
Average Days of Payables |
8.67 | 12.68 | 22.41 | 20.32 | |
Days of Inventory on Hand |
22.56 | 21.71 | 19.87 | 18.01 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.33% | |
Selling, General and Administrative Expense of Revenue |
21.51% | 23.66% | 24.17% | 24.17% | |
Share Based Compensation of Revenue |
2.30% | 2.62% | 2.73% | 2.70% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.37 | 0.12 | (0.49) | (0.57) | |
Depreciation/Fixed assets |
0.51 | 0.55 | 0.58 | 0.53 | |
Capex/Depreciation |
(0.33) | (0.21) | (0.29) | (0.48) | |
Revenue per Share |
20.98 | 19.25 | 17.17 | 17.53 | |
Operating CF per Share |
(0.58) | (0.18) | 0.68 | 0.73 | |
Capex per Share |
(0.24) | (0.15) | (0.18) | (0.30) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
(7.50%) | (7.67%) | (7.98%) | (7.33%) |
Columns are period end dates